Systemic Interventions for Treatment of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: Summary of a Cochrane Review.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 36260297.
- Also identified by DOI 10.1001/jamadermatol.2022.4543.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
What are the effects of systemic therapies for Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN)? There is limited high-quality evidence to support the use of systemic immunomodulatory therapies to decrease mortality rates in SJS/TEN.
Medical subject headings
- Stevens-Johnson Syndrome